Across 6 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the detailed record of transactions filed by Lederman Seth, Chairman & CEO. Insider active across 1 company, notably Tonix Pharmaceuticals Holding Corp.. Cumulatively, 7 disclosures have been logged. Split: 6 buys · 0 sell. Total volume traded: €386k. History available since 28 September 2021. The latest transaction was filed on 31 March 2026 (Acquisition). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Lederman Seth
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
12,000 shares@ US$0.611.6% of flowCommon Stock, $0.001 par valueSEC:0001387131-21-009696:0
Canonical exit: 27 Dec 2021 (T+90)
7 of 7 declarations
About Lederman Seth
LEDERMAN SETH is Président-Directeur Général and Chief Executive Officer of Tonix Pharmaceuticals Holding Corp. The 7 known filings, all within the 7 sampled filings, are acquisitions between 2021-09-28 and 2026-04-01, with buy volume of EUR 386340 and no sell volume.